T. Rowe Price Associates

T. Rowe Price Associates’s Inozyme Pharma INZY Stock Holding History

T. Rowe Price Associates’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$18K	Hold
2024 Q4	$55K	Buy
2024 Q3	$87K	Buy
2024 Q2	$74K	Buy
2024 Q1	$109K	Buy
2023 Q4	$55K	Buy